RSNA: Toshiba previews CT and MRI technologies, updates Viamo
Toshiba America Medical Systems is previewing various CT, MRI and ultrasound imaging technologies at Radiological Society of North America (RSNA) 2010 in Chicago.
As a work in progress, the company will highlight its 160-detector row helical scanning. Featured on the Aquilion One and Aquilion Premium, helical scanning can image the chest, abdomen and pelvis in less than five seconds, according to Toshiba. The imaging mode could be used for routine body imaging and for patients who have difficulty staying still during exams, such as trauma and pediatric patients.
The company also is introducing two new dose-reduction technologies, Target CTA and Adaptive Iterative Dose Reduction (AIDR), as works in progress. Target CTA is a new dose cardiac protocol for the Aquilion One that is designed for patients with stable heart rates, including pediatrics. Toshiba also will show the latest constructions of its AIDR technology, which is software that iterates noise out of the image to increase image quality and lower radiation dose. AIDR is pending 510(k) clearance and will come standard on the Aquilion Premium and Aquilion One.
Also, as a work in progress, the company will showcase its Titan 3T MR system, which uses Toshiba’s Pianissimo sound-reduction technology to reduce exam noise. The Titan 3T boasts a 71 cm aperture. Additionally, the Titan 3T incorporates the ability to perform contrast-free MR angiography exams utilizing Toshiba’s non-contrast sequences, which are now in their fourth generation. The Titan 3T also utilizes Toshiba’s Atlas coil technology.
Toshiba will unveil upgrades to its Viamo ultrasound system: the Viamo includes ApliPure Plus, Tissue Pure Imaging, a curved transducer and DICOM structured reporting. The company said its Viamo combines the portability of a laptop system with radiology features. The new upgrades on the Viamo allow clinicians to perform bedside exams for radiology, vascular and OB/GYN patients.
As a work in progress, the company will highlight its 160-detector row helical scanning. Featured on the Aquilion One and Aquilion Premium, helical scanning can image the chest, abdomen and pelvis in less than five seconds, according to Toshiba. The imaging mode could be used for routine body imaging and for patients who have difficulty staying still during exams, such as trauma and pediatric patients.
The company also is introducing two new dose-reduction technologies, Target CTA and Adaptive Iterative Dose Reduction (AIDR), as works in progress. Target CTA is a new dose cardiac protocol for the Aquilion One that is designed for patients with stable heart rates, including pediatrics. Toshiba also will show the latest constructions of its AIDR technology, which is software that iterates noise out of the image to increase image quality and lower radiation dose. AIDR is pending 510(k) clearance and will come standard on the Aquilion Premium and Aquilion One.
Also, as a work in progress, the company will showcase its Titan 3T MR system, which uses Toshiba’s Pianissimo sound-reduction technology to reduce exam noise. The Titan 3T boasts a 71 cm aperture. Additionally, the Titan 3T incorporates the ability to perform contrast-free MR angiography exams utilizing Toshiba’s non-contrast sequences, which are now in their fourth generation. The Titan 3T also utilizes Toshiba’s Atlas coil technology.
Toshiba will unveil upgrades to its Viamo ultrasound system: the Viamo includes ApliPure Plus, Tissue Pure Imaging, a curved transducer and DICOM structured reporting. The company said its Viamo combines the portability of a laptop system with radiology features. The new upgrades on the Viamo allow clinicians to perform bedside exams for radiology, vascular and OB/GYN patients.